In comparison to other neoplasms, patients with NF1 had considerably lower disease-specific survival (DSS) rates if they developed undifferentiated pleomorphic sarcoma (UPS), high- grade glioma (HGG), malignant peripheral nerve tumor (MPNST), ovarian cancer, or melanoma. This evidence concerns the gene NF1 and peripheral nervous system cancer.